08:32 EDT Protara Therapeutics files $300M mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on TARA:
- Protara Therapeutics Announces Third Quarter 2023 Financial Results and Business Update
- Protara Therapeutics doses first patient in Phase 2 STARBORN-1 trial of TARA-002
- Protara Therapeutics Announces Dosing of First Patient in Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations
- Guggenheim bullish on Protara after dosing of first patient in ADVANCED 2 trial
- Protara announces dosing of first patients in Phase 1b/2 ADVANCED-2 trial